• Home
  • Our Society
    • Board Members
    • ByLaws
    • Founding Members
    • Member List
    • Membership Form
    • Media
    • Press
  • News
  • Congress
    • Upcoming Congress
    • Previous Congress
  • Projects
    • Endo At School
    • The Higher Education Credit and Hostels Instituton
    • Corporate Awareness Meetings
  • EndoMarch
  • Library
    • Presentations
    • Journals
    • Videos
    • Article Summaries
  • Contact
  • +90 532 515 69 99
  • info@endometriozisdernegi.org
Youtube Instagram Facebook Twitter Linkedin
  • Türkçe
  • English
For Patients
  • Home
  • Our Society
    • Board Members
    • ByLaws
    • Founding Members
    • Member List
    • Membership Form
    • Media
    • Press
  • News
  • Congress
    • Upcoming Congress
    • Previous Congress
  • Projects
    • Endo At School
    • The Higher Education Credit and Hostels Instituton
    • Corporate Awareness Meetings
  • EndoMarch
  • Library

      Presentations

      Journals

      Videos

      Article Summaries

      Links

      Guidelines

      Bulletins

      Books

    • Presentations
    • Journals
    • Videos
    • Article Summaries
  • Contact
  • Home
  • Our Society
    • Board Members
    • ByLaws
    • Founding Members
    • Member List
    • Membership Form
    • Media
    • Press
  • News
  • Congress
    • Upcoming Congress
    • Previous Congress
  • Projects
    • Endo At School
    • The Higher Education Credit and Hostels Instituton
    • Corporate Awareness Meetings
  • EndoMarch
  • Library

      Presentations

      Journals

      Videos

      Article Summaries

      Links

      Guidelines

      Bulletins

      Books

    • Presentations
    • Journals
    • Videos
    • Article Summaries
  • Contact

Summary of Articles in March 2017

Article Summaries

  • 1- Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis. Hum Reprod 2017 Feb 9:1-14. doi: 10.1093/humrep/dex024.
  • 2- Soluble VCAM-1/soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis. Hum Reprod 2017 Feb 23:1-10. doi: 10.1093/humrep/dex028.
  • 3- Endometriosis education in schools: A New Zealand model examining the impact of an education program in schools on early recognition of symptoms suggesting endometriosis. Aust N Z J Obstet Gynaecol. 2017 Mar 28. doi: 10.1111/ajo.12614.
  • 4- Non-ART pregnancy predictive factors in infertile patients with peritoneal superficial endometriosis. Eur J Obstet Gynecol Reprod Biol 2017 Mar 7;211:182-187. doi: 10.1016/j.ejogrb.2017.03.008.
  • 5- Endometriosis is associated with aberrant metabolite profiles in plasma. Fertil Steril 2017 Mar;107(3):699-706.e6. doi: 10.1016/j.fertnstert.2016.12.032.
  • 6- Introduction: A focus on the medical management of endometriosis. Fertil Steril 2017 Mar;107(3):521-522. doi: 10.1016/j.fertnstert.2017.01.008.
  • 7- Mu opioid receptor in the human endometrium: dynamics of its expression and localization during the menstrual cycle. Fertil Steril 2017 Feb 27. pii: S0015-0282(17)30079-1. doi: 10.1016/j.fertnstert.2017.01.020.
  • 8- Clinicians' perceptions of women's experiences of endometriosis and of psychosocial care for endometriosis. Aust N Z J Obstet Gynaecol 2017 Feb;57(1):87-92. doi: 10.1111/ajo.12571.
  • 9- Genetic risk factors for ovarian cancer and their role for endometriosis risk. Gynecol Oncol 2017 Apr;145(1):142-147. doi: 10.1016/j.ygyno.2017.02.022.
  • 10- Biomarkers in endometriosis: challenges and opportunities. Fertil Steril 2017 Mar;107(3):523-532. doi: 10.1016/j.fertnstert.2017.01.009.
  • 11- Surgery for endometriosis: beyond medical therapies. Fertil Steril 2017 Mar;107(3):549-554. doi: 10.1016/j.fertnstert.2017.01.001.
  • 12- Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents. J Pediatr Adolesc Gynecol 2017 Feb 9. pii: S1083-3188(17)30036-0. doi: 10.1016/j.jpag.2017.01.014.
  • 13- Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 2017 Mar;107(3):533-536. doi: 10.1016/j.fertnstert.2017.01.003.
  • 14- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy. Fertil Steril 2017 Mar;107(3):537-548. doi: 10.1016/j.fertnstert.2016.12.024.
  • 15- Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis? Fertil Steril 2017 Mar;107(3):707-713.e3. doi: 10.1016/j.fertnstert.2016.12.013.
  • 16- Prognostic factors for assisted reproductive technology in women with endometriosis-related infertility. Am J Obstet Gynecol 2017 Mar;216(3):280.e1-280.e9. doi: 10.1016/j.ajog.2016.11.1042.
  • 17- Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density. Eur J Obstet Gynecol Reprod Biol 2017 Mar 6;212:9-12. doi: 10.1016/j.ejogrb.2017.03.011.
  • 18- Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol 2017 Apr;211:108-111. doi: 10.1016/j.ejogrb.2017.02.015.
  • 19- Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses. Cancer Causes Control 2017 Mar 15. doi: 10.1007/s10552-017-0856-4.

EndoMarch

Our association; was established to inform patients, relatives, the society, physicians about Endometriosis and the diseases caused by it. We are working for a future where the effects of Endometriosis, which is one of every 10 women of reproductive age, have less effects.
Read More

Endometriosis and Adenomyosis Society

www.endometriosisschool.com
Youtube Instagram Facebook Twitter Linkedin

Library

Presentations
Videos
Journals
Article Summaries
Guidelines
Books
Bulletins

Scientific Resources

www.endometriosis.org
www.endometriosisassn.org
www.endometriosis-uk.org
www.endofound.org
www.endocenter.org
www.endometriosisfoundation.org
www.apendoalliance.org

Address

Osmanağa Mah. Osmancık Sok. Betül Han No:9 D:4 Kadıköy, İstanbul, Turkey
Phone: +90 532 515 69 99
Email: info@endometriozisdernegi.org

Copyright 2020 - Endometriozis and Adenomyozis Society.
Share on